Published on 19.4.2023 in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40437, first published June 20, 2022.

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Crystal L Smith^{1, 2, 3}

; Abigail Keever^{1, 2, 3}

; Theresa Bowden^{2, 3, 4}

; Katie Olson⁵

; Nicole Rodin^{2, 3, 4}

; Michael G McDonell^{1, 3}

; John M Roll^{1, 3}

; Gillian Smoody²

; Jeff LeBrun⁶

; Andre QC Miguel^{1, 2, 3}

; Sterling M McPherson^{1, 2, 3}

Article Authors Cited by (1) Tweetations (2) Metrics

Journals

McPherson S, Smith C, Hall L, Miguel A, Bowden T, Keever A, Schmidt A, Olson K, Rodin N, McDonell M, Roll J, LeBrun J. Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I feasibility, usability and efficacy pilot randomized clinical trial. Drug and Alcohol Dependence 2024;256:111099 View